Better diagnostics for targeted antibiotic therapy

H. Goossens (Edegem (Antwerp), Belgium)

Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Session: Antibiotic resistance: the way forward
Session type: Symposium
Number: 3808

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Goossens (Edegem (Antwerp), Belgium). Better diagnostics for targeted antibiotic therapy. Virtual Congress 2020 – Antibiotic resistance: the way forward

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Biomarkers and rapid diagnostics in antibiotic stewardship
Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Year: 2015

Meta-analysis may not be practicable for guiding antibiotic therapy
Source: Eur Respir J 2008; 31: 906-907
Year: 2008

Optimizing the target therapy development
Source: ERS Research Seminar
Year: 2015

Long-term antibiotic therapy
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017

The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017

Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012

Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021

Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Source: Eur Respir J 2013; 42: 1449-1453
Year: 2013

New methodologogic approaches to the management of antituberculous service
Source: Eur Respir J 2003; 22: Suppl. 45, 381s
Year: 2003

Combination therapy in the era of immunotherapy
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019

Paradox radiologic progression despite appropriate antituberculosis therapy
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011

Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008

Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Year: 2021

Antimicrobial resistance and new therapeutic options
Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era
Year: 2021

Concomitant radiotherapy and targeted therapies
Source: International Congress 2019 – New perspectives in thoracic surgical oncology
Year: 2019

Rational use of tuberculosis drugs to prevent the development of drug resistance
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012